SEC Form 4 · accession 0001209191-15-079940
AYTU BIOPHARMA, INC · AYTU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua R. Disbrow
Officer — Chief Executive Officer
Period of report
Nov 11, 2015
Accepted (ET)
Nov 13, 2015 · 8:22 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385818
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option GrantF1 | $1.51 | Nov 11, 2015 | A | 600,000 | A | — | Nov 11, 2025 | Common Stock | 600,000 | 600,000 | D |
Explanation of responses
- F133.33% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.